Consensus Livzon Pharmaceutical Group Inc.

Equities

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-07 pm EDT			5-day change	1st Jan Change
40.48 ^CNY	-0.17%		+0.95%	+15.62%

Apr. 26	Livzon Pharmaceutical Factory Receives Approval for the U.S. FDA Approval for the Company's Drug Cetrorelix Acetate for Injection	CI
Apr. 24	Livzon Pharmaceutical's Q1 Profit Jumps 4.5%; Revenue Slips 5%	MT

fb727.JABJwyoc4BMn2Nr9wGxw33yXfbZpU9ncfEthoee7tv0.XlF_uVJD10N2uoi3tVUG8gWhF94IF-mqBHhX04yOzq5QNS2PZUyII2jqvQ~84bf11ce87af7d7efd6bf263c218e4cd

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

40.48 CNY

Average target price

41.14 CNY

Spread / Average Target

+1.63%

High Price Target

47.5 CNY

Spread / Highest target

+17.34%

Low Price Target

31.43 CNY

Spread / Lowest Target

-22.36%

Trading Rating

Investor Rating

ESG Refinitiv

B+